SEC Filing Summary: BioSig Technologies, Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on January 13, 2021. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The filing serves as a Regulation FD disclosure regarding an upcoming investor presentation.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report announcing a presentation and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates are reported in this filing. The document solely announces a scheduled event.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Kenneth L. Londoner, Chairman and CEO, is scheduled to present at the Sidoti Winter 2021 Investor Conference on January 13, 2021, at 2:30 PM ET.
- Materials: A slide presentation (Exhibit 99.1) is attached and incorporated by reference.
- Legal Disclaimer: The Company explicitly states it undertakes no obligation to update, supplement, or amend the presentation materials. The information is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the company name is BioSig Technologies, Inc. (BSGM), as the request metadata incorrectly listed "Streamex Corp."
- Review Exhibit 99.1 (the attached slide presentation) for actual business updates, as the 8-K text itself contains no operational details.
- Note that the presentation materials are not legally "filed" and the company disclaims any obligation to update them.
- Confirm the presentation date and time: January 13, 2021, at 2:30 PM ET.